Compounded GLP-1 products are marketed using semaglutide or tirzepatide formulations, but they are distinct from FDA-approved finished brand-name drugs like Ozempic, Wegovy, Zepbound, or Mounjaro
When a drug is listed as "currently in shortage," compounding pharmacies can produce copies under Section 503A without violating the FDA's prohibition on compounding copies of commercially available drugs
From the perspective of oral GLP-1 drug development trends, these developments signal a critical turning point for pharmaceutical innovation and global drug supply
Potential Benefits of the Combination Why would a healthcare provider consider using both medications
It has become increasingly clear that cells produce not only glucagon, but also GLP-1, although the latter was produced at much lower level than the former 22,23,24,25,26,27
According to experts, weight loss from a GLP-1 could also lead to a lack of hydration and collagen and lead to looser skin that amplifies fine lines and wrinkles